Product Code: ETC9964616 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 | |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 United States (US) Drug Testing Market Overview |
3.1 United States (US) Country Macro Economic Indicators |
3.2 United States (US) Drug Testing Market Revenues & Volume, 2021 & 2031F |
3.3 United States (US) Drug Testing Market - Industry Life Cycle |
3.4 United States (US) Drug Testing Market - Porter's Five Forces |
3.5 United States (US) Drug Testing Market Revenues & Volume Share, By Component, 2021 & 2031F |
3.6 United States (US) Drug Testing Market Revenues & Volume Share, By Sample Type, 2021 & 2031F |
3.7 United States (US) Drug Testing Market Revenues & Volume Share, By Drug Type, 2021 & 2031F |
3.8 United States (US) Drug Testing Market Revenues & Volume Share, By End Use, 2021 & 2031F |
4 United States (US) Drug Testing Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness and regulations regarding workplace drug testing |
4.2.2 Rising incidence of drug abuse and addiction in the United States |
4.2.3 Growing adoption of drug testing in healthcare settings |
4.3 Market Restraints |
4.3.1 High costs associated with drug testing procedures |
4.3.2 Legal and ethical concerns related to privacy and discrimination |
4.3.3 Lack of standardization in drug testing practices across different industries |
5 United States (US) Drug Testing Market Trends |
6 United States (US) Drug Testing Market, By Types |
6.1 United States (US) Drug Testing Market, By Component |
6.1.1 Overview and Analysis |
6.1.2 United States (US) Drug Testing Market Revenues & Volume, By Component, 2021- 2031F |
6.1.3 United States (US) Drug Testing Market Revenues & Volume, By Consumables, 2021- 2031F |
6.1.4 United States (US) Drug Testing Market Revenues & Volume, By Instruments, 2021- 2031F |
6.1.5 United States (US) Drug Testing Market Revenues & Volume, By Rapid Testing Devices, 2021- 2031F |
6.1.6 United States (US) Drug Testing Market Revenues & Volume, By Services, 2021- 2031F |
6.2 United States (US) Drug Testing Market, By Sample Type |
6.2.1 Overview and Analysis |
6.2.2 United States (US) Drug Testing Market Revenues & Volume, By Urine samples, 2021- 2031F |
6.2.3 United States (US) Drug Testing Market Revenues & Volume, By Oral Fluid Samples, 2021- 2031F |
6.2.4 United States (US) Drug Testing Market Revenues & Volume, By Hair Sample, 2021- 2031F |
6.2.5 United States (US) Drug Testing Market Revenues & Volume, By Other Samples, 2021- 2031F |
6.3 United States (US) Drug Testing Market, By Drug Type |
6.3.1 Overview and Analysis |
6.3.2 United States (US) Drug Testing Market Revenues & Volume, By Alcohol, 2021- 2031F |
6.3.3 United States (US) Drug Testing Market Revenues & Volume, By Cannabis/Marijuana, 2021- 2031F |
6.3.4 United States (US) Drug Testing Market Revenues & Volume, By Cocaine, 2021- 2031F |
6.3.5 United States (US) Drug Testing Market Revenues & Volume, By Opioids, 2021- 2031F |
6.3.6 United States (US) Drug Testing Market Revenues & Volume, By Amphetamine & Methamphetamine, 2021- 2031F |
6.3.7 United States (US) Drug Testing Market Revenues & Volume, By LSD, 2021- 2031F |
6.4 United States (US) Drug Testing Market, By End Use |
6.4.1 Overview and Analysis |
6.4.2 United States (US) Drug Testing Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.4.3 United States (US) Drug Testing Market Revenues & Volume, By Clinics, 2021- 2031F |
6.4.4 United States (US) Drug Testing Market Revenues & Volume, By Other End Uses, 2021- 2031F |
7 United States (US) Drug Testing Market Import-Export Trade Statistics |
7.1 United States (US) Drug Testing Market Export to Major Countries |
7.2 United States (US) Drug Testing Market Imports from Major Countries |
8 United States (US) Drug Testing Market Key Performance Indicators |
8.1 Percentage increase in the number of workplace drug testing programs implemented annually |
8.2 Average turnaround time for drug test results |
8.3 Number of drug testing labs accredited by regulatory bodies |
8.4 Adoption rate of advanced drug testing technologies |
8.5 Percentage of positive drug test results in the United States |
9 United States (US) Drug Testing Market - Opportunity Assessment |
9.1 United States (US) Drug Testing Market Opportunity Assessment, By Component, 2021 & 2031F |
9.2 United States (US) Drug Testing Market Opportunity Assessment, By Sample Type, 2021 & 2031F |
9.3 United States (US) Drug Testing Market Opportunity Assessment, By Drug Type, 2021 & 2031F |
9.4 United States (US) Drug Testing Market Opportunity Assessment, By End Use, 2021 & 2031F |
10 United States (US) Drug Testing Market - Competitive Landscape |
10.1 United States (US) Drug Testing Market Revenue Share, By Companies, 2024 |
10.2 United States (US) Drug Testing Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |